2 results match your criteria: "China Center for Disease Control and Prevention (CDC)[Affiliation]"
The state of biosafety across China's CDC microbiology laboratories: insights from a nationwide survey (2021-2023).
Front Public Health
August 2024
NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention (CDC), Beijing, China.
Background: The COVID-19 pandemic underscored the critical importance of biosafety in microbiology laboratories worldwide. In response, China has ramped up its efforts to enhance biosafety measures within its Centers for Disease Control and Prevention (CDC) laboratories. This study provides the first comprehensive assessment of biosafety practices across provincial, city, and county levels of CDC microbiology laboratories in China.
View Article and Find Full Text PDFPrevalence of tuberculosis drug resistance in 10 provinces of China.
BMC Infect Dis
December 2008
National Center for TB control and prevention, China Center for Disease Control and Prevention (CDC), Beijing, PR China.
Background: The emergence of drug-resistant tuberculosis (TB) hampers TB control. Ten provinces in China performed drug resistance surveys among tuberculosis (TB) patients in 1996-2004 to assess levels of drug resistance.
Methods: Provincial drug resistance surveys included all isolates from newly diagnosed, smear-positive TB patients.